Duration of therapy possibly should be 3-6 months or more since it is demonstrated that in kidney transplant patients high FGF23 levels may sustain for this period even when overt hypophosphatemia exists [141, 142], suggesting autonomous FGF23 production, which vanishes only after time. Here, FGF23 is linked to hypophosphatemia.